CBL Path, Inc.
Project ID
60023
Facility Name
CBL Path, Inc.
Analyte
MYD88 L265P mutation analysis
Method
real-time PCR
Specimen Type
tissue: FFPE; whole blood; bone marrow
Permit Category
Oncology - Molecular and Cellular Tumor Markers
Status
Approved
Facility State
NY
Facility ID
3954